Skip to content
DraconiticResearch
Search Sources API
179,152 studies31 sourcesUpdated 12 min ago
PreprintCC BY-NC-NDmedRxiv

High-frequency EEG activity moderates the association between amyloid burden and tau in cognitively normal adults

  1. 1Weill Cornell Medicine

Abstract

Background: Resting electroencephalogram (EEG) may capture early excitatory-inhibitory (E-I) imbalance in Alzheimer's disease, but its relationship to beta-amyloid and tau in cognitively normal adults is unclear. Methods: We analyzed resting-state EEG from 24 older adults, 21 cognitively normal (13 beta-amyloid-negative, 8 beta-amyloid-positive) and 3 with MCI/AD (all beta-amyloid-positive), with beta-amyloid positron emission tomography (PET); 20 of the cognitively normal adults also had tau PET. Four parietal measures related to E-I balance and excitability (periodic gamma power, alpha-gamma and theta-gamma phase-amplitude coupling [PAC], and the aperiodic exponent) were related to beta-amyloid burden and to early medial temporal lobe (MTL) tau, adjusting for age and sex. Results: In 21 cognitively normal adults, higher beta-amyloid burden was associated with higher parietal periodic gamma power (beta= +0.50, p = 0.025). No E-I measure was associated with MTL tau across all participants. However, in beta-amyloid-positive adults, higher periodic gamma was associated with higher MTL tau, most strongly in the entorhinal cortex (beta = +0.90, p = 0.002), with no association in beta-amyloid-negative adults. Importantly, periodic gamma also moderated the association between beta-amyloid and MTL tau (p = 0.012; consistent across MTL regions after FDR correction). Conclusions: In this pilot study, parietal periodic gamma, an EEG marker of cortical excitability, increased with beta-amyloid burden and was related to MTL tau only in the presence of beta-amyloid. Periodic gamma is a candidate marker of beta-amyloid-related E-I imbalance that warrants confirmation in larger samples.

Related

  1. EEG-based brain effective and functional connectivity predict PET-defined amyloid positivity in cognitively normal individuals.
    Boxin Sun, Ming Gu, Amanda Maher +10
    Alzheimer's & dementia : the journal of the Alzheimer's AssociationPeer-reviewedCC BY-NCFull textPsychiatry & mental healthEurope PMCPMC
  2. White matter hyperintensities and amyloid pathology in cognitively unimpaired aging: topographical, microstructural, and network-level evidence
    Sana Mohammadi, Sana Mohammadi, Minoo Sharbafshaaer +14
    Frontiers in Aging NeurosciencePeer-reviewedCC BYFull textPsychiatry & mental healthDOAJ
  3. Direction-specific biomarker profiles and clinical significance of plasma p-tau217/amyloid PET discordance in cognitively normal adults.
    Yanlu Huang, Lin Huang, Liang Cui +5
    Alzheimer's & dementia : the journal of the Alzheimer's AssociationPeer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthEurope PMC
  4. Basal Forebrain Volume is Associated With Cortical Amyloid Burden in Cognitively Unimpaired Older Adults at Varying Genetic Risk for Alzheimer's Disease.
    Gawon Cho, Kaitlin Kelly, Takuya Toyonaga +6
    The American journal of geriatric psychiatry. Open science, education, and practicePeer-reviewedCC BYFull text2 citedPsychiatry & mental healthEurope PMC
  5. Plasma p-tau181 moderates the association between ten-year atherosclerotic cardiovascular disease risk and mild cognitive impairment – HABS-HD
    Joey A. Contreras, Nancy E. Ortega, Raymond Jones +2
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@misc{hojjati2026highfrequency,
  title = {{High-frequency EEG activity moderates the association between amyloid burden and tau in cognitively normal adults}},
  author = {S. H. Hojjati and A. Radanovic and I. Martin and L. Alkhoury and T. H. Butler and N. Foldi and S. A. Shah and G. C. Chiang},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.30.26366850},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.30.26366850v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - High-frequency EEG activity moderates the association between amyloid burden and tau in cognitively normal adults
AU  - S. H. Hojjati
AU  - A. Radanovic
AU  - I. Martin
AU  - L. Alkhoury
AU  - T. H. Butler
AU  - N. Foldi
AU  - S. A. Shah
AU  - G. C. Chiang
PY  - 2026
DA  - 2026/10/30
PB  - medRxiv
DO  - 10.64898/2026.10.30.26366850
UR  - https://www.medrxiv.org/content/10.64898/2026.10.30.26366850v1
AB  - Background: Resting electroencephalogram (EEG) may capture early excitatory-inhibitory (E-I) imbalance in Alzheimer's disease, but its relationship to beta-amyloid and tau in cognitively normal adults is unclear. Methods: We analyzed resting-state EEG from 24 older adults, 21 cognitively normal (13 beta-amyloid-negative, 8 beta-amyloid-positive) and 3 with MCI/AD (all beta-amyloid-positive), with beta-amyloid positron emission tomography (PET); 20 of the cognitively normal adults also had tau PET. Four parietal measures related to E-I balance and excitability (periodic gamma power, alpha-gamma and theta-gamma phase-amplitude coupling [PAC], and the aperiodic exponent) were related to beta-amyloid burden and to early medial temporal lobe (MTL) tau, adjusting for age and sex. Results: In 21 cognitively normal adults, higher beta-amyloid burden was associated with higher parietal periodic gamma power (beta= +0.50, p = 0.025). No E-I measure was associated with MTL tau across all participants. However, in beta-amyloid-positive adults, higher periodic gamma was associated with higher MTL tau, most strongly in the entorhinal cortex (beta = +0.90, p = 0.002), with no association in beta-amyloid-negative adults. Importantly, periodic gamma also moderated the association between beta-amyloid and MTL tau (p = 0.012; consistent across MTL regions after FDR correction). Conclusions: In this pilot study, parietal periodic gamma, an EEG marker of cortical excitability, increased with beta-amyloid burden and was related to MTL tau only in the presence of beta-amyloid. Periodic gamma is a candidate marker of beta-amyloid-related E-I imbalance that warrants confirmation in larger samples.
ER  -